Literature DB >> 26733498

Secretome profile analysis of hypervirulent Mycobacterium tuberculosis CPT31 reveals increased production of EsxB and proteins involved in adaptation to intracellular lifestyle.

Fernado Vargas-Romero1, Nora Guitierrez-Najera2, Guillermo Mendoza-Hernández3, Daniel Ortega-Bernal1, Rogelio Hernández-Pando4, Mauricio Castañón-Arreola5.   

Abstract

Epidemiological information and animal models have shown various Mycobacterium tuberculosis phenotypes ranging from hyper- to hypovirulent forms. Recent genomic and proteomic studies suggest that the outcome of infection depends on the M. tuberculosis fitness, which is a direct consequence of its phenotype. However, little is known about the molecular and cellular mechanisms used by mycobacteria to survive, replicate and persist during infection. The aim of this study was to perform a comprehensive proteomic analysis of culture filtrate from hypo- (CPT23) and hypervirulent (CPT31) M. tuberculosis isolates. Using two-dimensional electrophoresis we observed that 70 proteins were unique, or more abundant in culture filtrate of CPT31, and 15 of these were identified by mass spectrometry. Our analysis of protein expression showed that most of the proteins identified are involved in lipid metabolism (FadA3, FbpB and EchA3), detoxification and adaptation (GroEL2, SodB and HspX) and cell wall processes (LprA, Tig and EsxB). These results suggest that overrepresented proteins in M. tuberculosis CPT31 secretome could facilitate mycobacterial infection and persistence. © FEMS 2016. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Mycobacterium tuberculosis; hypervirulent; lifestyle; secretome profile

Mesh:

Substances:

Year:  2016        PMID: 26733498     DOI: 10.1093/femspd/ftv127

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  6 in total

1.  Comprehensive profiling of functional attributes, virulence potential and evolutionary dynamics in mycobacterial secretomes.

Authors:  Ayan Roy; Arnab Sen; Sourav Chakrobarty; Indrani Sarkar
Journal:  World J Microbiol Biotechnol       Date:  2017-12-04       Impact factor: 3.312

2.  Cytosolic Proteome Profiling of Aminoglycosides Resistant Mycobacterium tuberculosis Clinical Isolates Using MALDI-TOF/MS.

Authors:  Divakar Sharma; Manju Lata; Rananjay Singh; Nirmala Deo; Krishnamurthy Venkatesan; Deepa Bisht
Journal:  Front Microbiol       Date:  2016-11-15       Impact factor: 5.640

Review 3.  Sharpening Host Defenses during Infection: Proteases Cut to the Chase.

Authors:  Natalie C Marshall; B Brett Finlay; Christopher M Overall
Journal:  Mol Cell Proteomics       Date:  2017-02-08       Impact factor: 5.911

4.  Mycobacterium tuberculosis Cpn60.2 (GroEL2) blocks macrophage apoptosis via interaction with mitochondrial mortalin.

Authors:  Sunil Joseph; Alex Yuen; Vijender Singh; Zakaria Hmama
Journal:  Biol Open       Date:  2017-04-15       Impact factor: 2.422

5.  Secretome Prediction of Two M. tuberculosis Clinical Isolates Reveals Their High Antigenic Density and Potential Drug Targets.

Authors:  Fernanda Cornejo-Granados; Zyanya L Zatarain-Barrón; Vito A Cantu-Robles; Alfredo Mendoza-Vargas; Camilo Molina-Romero; Filiberto Sánchez; Luis Del Pozo-Yauner; Rogelio Hernández-Pando; Adrián Ochoa-Leyva
Journal:  Front Microbiol       Date:  2017-02-07       Impact factor: 5.640

Review 6.  The genetic proteome: Using genetics to inform the proteome of mycobacterial pathogens.

Authors:  Kathleen R Nicholson; C Bruce Mousseau; Matthew M Champion; Patricia A Champion
Journal:  PLoS Pathog       Date:  2021-01-07       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.